LupusHumansFemaleLupus ErythematosusSystemicAntiphospholipid Syndrome
A high level of sTREM-1 predicts occurrence of thrombosis, obstetrical event or death in a prospective cohort of patients with antiphospholipid antibodies and/or systemic lupus. Results of the APLART study.
Virginie Dufrost, Thomas Foret, Thomas Moulinet, Jeremy Lagrange, Adrien Jacquot, Cédric Baumann, Isabelle Clerc-Urmès, Valérie Eschwège, Cécile Lakomy, Katrien M J Devreese, Patrick Lacolley, Veronique Regnault, Sébastien Gibot, Stéphane Zuily, Denis Wahl
Published: 202510.1177/09612033251396268
Abstract
ObjectivesThe main challenge in the care of patients with primary antiphospholipid syndrome (APS) or associated to systemic lupus erythematosus (SLE) is to determine whether patients will experience new events that may impair their clinical outcome.…
Preview only. Read the full abstract at the source